Doxycycline Hyclate Capsules

Doxycycline Hyclate Capsules



Status:ANDA 209402

Product Detail

Doxycycline hyclate Capsules and Tablets, we have got ANDA approval since Oct,2019;now the sales amount is around USD2 million in US market; And we plan to register in South East Asia and other markets.

Indication and Usage:

Doxycycline hyclate Capsules:

To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.